ARA-290 10 mg Research Peptide
ARA-290 is a synthetic peptide derived from a tissue-protective region of erythropoietin (EPO). In research settings, it has been investigated for its interaction with innate repair receptor pathways and cellular signaling mechanisms associated with inflammation, tissue protection, and nerve-related research models.
ARA-290 is an 11-amino acid peptide engineered to retain specific tissue-protective signaling characteristics while avoiding erythropoietic activity associated with EPO. Researchers have explored its applications in studies involving inflammatory pathways, neurological function, and cellular repair processes.
Specifications
| Compound | ARA-290 10mg |
|---|---|
| Category | Peptide |
| SKU | GRL-ARA290-10 |
| Unit size | 10 mg |
| Price | $40.00 |
| Availability | Out of stock |
| Intended use | Laboratory research use only |
Compound identity
Reference facts for the compound itself, from PubChem (NIH). They describe the molecule, not a specific batch — batch purity is reported on the certificate of analysis.
| CAS Registry Number | 1208243-50-8 |
|---|---|
| Molecular formula | C51H84N16O21 |
| Molecular weight | 1257.3 g/mol |
| PubChem name | Cibinetide |
| PubChem CID | 91810664 |
ARA-290 10mg is also written ARA-290, ARA-290 peptide, ARA290, ARA290 peptide and ARA 290.
Research questions about this compound
Is ARA-290 an erythropoietin analog?
It is derived from the erythropoietin molecule, but it is engineered specifically to avoid the erythropoietic effects of the parent hormone . It is classified as an innate repair receptor agonist .
What does the evidence say about its effect on blood pressure?
The current human clinical trials, including the study on type 2 diabetes, have not reported significant adverse cardiovascular events or fluctuations in blood pressure directly attributed to the administration of the peptide .
Can this peptide cure neuropathy?
The research does not use the term "cure." Clinical studies have observed a reduction in pain scores and improvements in neuropathic symptoms in specific patient populations, but these findings do not equate to a permanent resolution of the underlying condition , .
How does ARA-290 differ from standard pain medications?
Standard pain medications often target neurotransmitter receptors or ion channels to dampen pain signaling. ARA-290 is designed to modulate inflammation and support nerve cell survival via the innate repair receptor, representing a different therapeutic mechanism entirely .
labels, lab notebooks, reorders
ARA-290 10mg — Reconstitution Calculator
For laboratory research use only. This tool computes the concentration of a reconstituted research solution and the volume that contains a target mass. Vial mass is a product specification, not a dose. It is not medical guidance and does not describe administration to humans or animals.
For laboratory research use only · not for human or animal use. Doses-per-bottle is pure arithmetic (vial mass ÷ target amount), not a dosing recommendation.
Compare ARA-290 10mg and Bacteriostatic water, 30 ml. catalog facts →
